GTEx BloodVessel 20-29 vs 60-69 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx BloodVessel 20-29 vs 60-69 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx BloodVessel 20-29 vs 60-69 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx BloodVessel 20-29 vs 60-69 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx BloodVessel 20-29 vs 60-69 Down.

Results found

Linked to

 

Label

Description

 

Gene

HOX transcript antisense RNA

Gene

HOXA cluster antisense RNA 3

Gene

CENPB DNA-binding domain containing 1, pseudogene

Gene

long intergenic non-protein coding RNA 1139

Gene

HOXA10 antisense RNA

Gene

SNX10 antisense RNA 1

Gene

prostate androgen-regulated transcript 1

Gene

HERC2 pseudogene 5

Gene

long intergenic non-protein coding RNA 1124

Gene

G protein pathway suppressor 2 pseudogene 1

  • Gene

    HOX transcript antisense RNA


  • Gene

    HOXA cluster antisense RNA 3


  • Gene

    CENPB DNA-binding domain containing 1, pseudogene


  • Gene

    long intergenic non-protein coding RNA 1139


  • Gene

    HOXA10 antisense RNA


  • Gene

    SNX10 antisense RNA 1


  • Gene

    prostate androgen-regulated transcript 1


  • Gene

    HERC2 pseudogene 5


  • Gene

    long intergenic non-protein coding RNA 1124


  • Gene

    G protein pathway suppressor 2 pseudogene 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.